Featured
Advertisement
Trending - Altmetric
-
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
-
Activation or exhaustion of CD8+ T cells in patients with COVID-19
-
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
-
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications